Healthy Living & Work
Diseases and chronic disorders related to our lifestyle are on the increase. We must, therefore, look at health and care in a different way, and combine prevention and treatment. At TNO, we’re working on social and technological innovations that help people make choices for better health and greater participation in society.
Promoting health with innovations for self-determination
‘We want to help people make the right choices for their health, employability, and productivity. It's not easy when you see what we have to deal with every day. For example, working longer in a healthy way, an often busy or intense living environment, and an intensive lifestyle,’ says TNO's Peter van Dijken.
Together with government agencies, knowledge institutes, and companies, we develop technological and social innovations that improve health and professional employability. In this way, they contribute to:
- a healthy, vital, and productive population
- lower healthcare costs
- more economic growth
Healthy Living active in 6 domains
The Healthy Living unit is active within 6 expertise groups:
- Risk Analysis for Products In Development (RAPID)
- Microbiology & Systems Biology Expertise Group
- Metabolic Health Research Expertise Group
- Child Health Expertise Group
- Work Health Technology Expertise Group
- Sustainable Productivity & Employability
We’re good at identifying major future developments and interventions relevant to these domains. Within the domains, we develop knowledge and expertise in health, health technology, and customised health interventions. Health interventions are methods and technologies that can be used when someone's health is at risk.
For example, we’re contributing to the transformation of youth healthcare through digitalisation. We’re developing an online platform that provides guidelines for youth healthcare and gives parents access to the professionals and advice they need to make the right choices. In addition, we measure and monitor stress and exposure to harmful substances in everyday life.
This leads us to collective public health strategies, personalised intervention strategies, and evidence-based health interventions, especially for the work environment. This creates a basis for interventions and assistive technology to improve both prevention and participation.
We want to significantly reduce the failure rate and thus the development costs of much-needed new drugs. We do this by innovating in the preclinical and clinical phases of drug development.
We also help the general public and professionals make healthy choices by collecting data on health and risks at a personal level. We convert them into valuable information, which we use to provide proactive, tailor-made advice. This personal information supports structural behavioural changes and a healthier lifestyle. We’re convinced that a change in lifestyle is the cure of the future for many diseases.
How do we improve the quality of digital healthcare?
Healthcare is digitalising at a rapid pace. This allows you to collect a lot of data and gain insight into genetic, lifestyle, and environmental factors. We develop useful, safe, and reliable applications that meet everyone's need for personalised healthcare. Privacy is a prerequisite.
We develop interpretations and predictive models of the personal health data for reliable advice and personalised interventions. We’re trying to improve personalised digital health with practical pilots.
Arjen AmelinkFunctie:Principal Scientist Medical Photonics
The chair focuses on the development and clinical validation of new optical diagnostic methods, with an emphasis on the interpretation of data generated by optical measurement systems based on the modeling of light transport in biological tissues.
Ben van OmmenFunctie:Principal Scientist Specialist
Looking for another expert?View all experts
Discover hybrid working 2.0: virtual meetings in the metaverse
Positive experiences of remote working are leading us to insights for new innovations. Our latest innovation: work meetings in the metaverse.
Group Care for pregnant women: A game changer for maternal and child care
Approximately 800 women die every day from preventable causes related to pregnancy and childbirth. Group care breaks the vicious circle of poor quality and inadequate utilization of services by offering care that addresses health holistically. It also focuses on health promotion and information and meets the needs of the end users. TNO and partners co-create strategies, learn implementation lessons and build ecosystems for learning and adaptation to bring group care to scale in seven countries.
TNO innovations addressing mental health of children
BoB, TNO’s methodology for teaching children resilience and stress management in South Sudan has proven successful and effective, and is ready for upscaling.
TNO helps accelerate drug development through insight
To find the most effective interventions for complex metabolic diseases, we must first understand the dynamics of disease onset and progression. Only then can key targets and optimal therapeutic windows for more effective treatment be defined. We spoke with Anita van den Hoek, Research Scientist for TNO Metabolic Health, about how TNO helps pharmaceutical companies accelerate drug development through better understanding of disease pathways.
TNO proves method for effective pediatric drug development
Safe and effective drug dosing for young children come with their own challenges. Up to the age of 18, a child’s metabolism can change significantly. And in the first two years of life, those ontogenic differences can be rapid and dramatic. TNO published its findings from the first drug disposition (mass balance/metabolite profiling) study to conclusively prove that microtracing with accelerator mass spectrometry (AMS) is an effective way to collect clinical data in these young patients. This AMS technology can also be the key to building up more data on drug interventions in pregnant and lactating mothers.